The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Open accessAbstract
In triple-negative breast cancer (TNBC), the benefit of combining chemotherapy with checkpoint inhibitors is still not very clear. We utilize single-cell RNA- and ATAC-sequencing to examine the immune cell dynamics in 22 patients with advanced TNBC treated with paclitaxel or its combination with the anti-PD-L1 atezolizumab. We demonstrate that high levels of baseline CXCL13 + T cells are linked to the proinflammatory features of macrophages and can predict effective responses to the combination therapy. In responsive patients, lymphoid tissue inducer (LTi) cells, follicular B (Bfoc) cells, CXCL13 + T cells, and conventional type 1 dendritic cells (cDC1) concertedly increase following the combination therapy, but instead decrease after paclitaxel monotherapy. Our data highlight the importance of CXCL13 + T cells in effective responses to anti-PD-L1 therapies and suggest that their reduction by paclitaxel regimen may compromise the clinical outcomes of accompanying atezolizumab for TNBC treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cell subsets show different responses to anti-PD(L)-1 therapies,”
From Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer (2025) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Applying ICB and combination therapies as neoadjuvant treatments provides an opportunity to observe immune cell dynamics in tumor microenvironment (TME) with temporal samples.”
From Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 792
Alaa, A. R., El-Din, S. A. B., Farrag, M. A., Ahmed, Y., Aziz, M. E. A., Abdel-Ghany, S. E., Arneth, B., & Sabit, H. (2026) · Biomedicines · doi:10.3390/biomedicines14092013 · Cited by 1
Breast cancer: recent advances in molecular approaches
Shen, Y., Zhang, D., & Ye, Q. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.03.003 · Cited by 1
Dong, J., Wang, Q., Wang, R., Ye, K., Ye, Z., Lin, J., Liang, H., & Wang, W. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1972 · Cited by 1
Song, P., Tian, W., Zheng, Y., Xu, S., Hu, Z., Jin, X., Zhu, X., Tan, L., Chen, D., & Chen, Y. (2025) · MedComm · doi:10.1002/mco2.70171 · Cited by 1
Ren, X.-C., Ma, Y., Li, J., Liu, Y., Liao, X., Lin, R., & Qiu, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-02702-0 · Cited by 1
Ren, Y., Niu, L., Dong, X., Wang, Y., Huang, X., & Zhao, X. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf096 · Cited by 1
Self-citationShareef, A., Sameer, H. N., Yaseen, A., Athab, Z. H., Adil, M., & Allela, O. Q. B. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104872 · Cited by 1
Chen, W., Teo, J. M. N., Yau, S. W., Wong, Y.-M. M., Lok, C., Che, C., Javed, A., Huang, Y., Ma, S., & Ling, G. S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4055642 · Cited by 1
Al‐Eryani, G., Bartoniček, N., Chan, C., Anderson, A., Harvey, K., Wu, S. Z., Roden, D., Wang, T., Reeves, J., Yeung, B. Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.31.494081 · Cited by 1
Klempner, S. J., Lee, J., Mehta, A., An, M., Min, B., Heo, Y. J., Parikh, M., Bi, L., Cristescu, R., Lee, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2793348/v1 · Cited by 1
Pan-cancer single-cell RNA sequencing analysis refines multi-origin monocyte and macrophage lineagesPreprint
Park, W., Nguyen, T. D. T., Park, H. J., Lee, D., Shah, N., & Mandzhieva, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3229780/v1 · Cited by 1
Gu, J., Guo, W., Li, X., Wang, D., Yan, N., Hu, Q., Yang, F., Zhang, X., & Yao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3749896/v1 · Cited by 1
Defining cellular determinants of resistance to PD-1 pathway blockade in non-small-cell lung cancerPreprint
Liu, B., Feng, K., Yu, K., Gao, R., Hu, X., Qin, B., Wang, J., Xue, Z., Han, W., & Zhang, Z. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.06.597777 · Cited by 1
Self-citationRuppin, E., Dhruba, S. R., Sahni, S., Wang, B., Wu, D., Rajagopal, P. S., Gurevich, Y., Shulman, E. D., Sinha, S., Sammut, S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4583538/v1 · Cited by 1
Zhao, Q., Li, X., Zhao, Z., Cheng, Y., Yan, J., Ren, F., Jia, Y., Li, J., Wang, B., Liu, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4589423/v1 · Cited by 1
Traxel, S., Schmidt, F., Beerli, C., Vuong, D.-V., Speck, R. F., & Bredl, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.01.615826 · Cited by 1
Pinhasi, A., & Yizhak, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.16.623986 · Cited by 1
Pan-cancer tumor classification by a holistic tumor microenvironment atlasPreprint
Qin, S., Xiao, D., Li, J., Jiang, N., Diao, T., Bo, Y., Gao, Q., Zheng, L., Ling, X., Gao, Q., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.27.696641 · Cited by 2
Self-citationIdentification and Validation of Immune-Related Gene Prognostic Signature for breast cancerPreprint
Zhou, B., Zhang, L., Wang, Q., Pu, C., Guo, S., Lai, S., Zhang, H., Li, W., Zhou, Z., Chen, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-386385/v1
Single cell profiling of bronchoalveolar immune cells in checkpoint inhibitor-related pneumonitisPreprint
Cui, P., Li, J., Tao, H., Li, X., Wu, L., Ma, J., Wang, H., Huang, D., Huang, Z., Chen, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1341170/v1
Yang, X., Tang, W., He, Y., An, H., & Wang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1941091/v1
Li, H., Santos, P., Kulkarni, A., Joglekar, A. V., Vujanovic, L. N., & Ferris, R. L. (2022) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2022-sitc2022.1037
Gui, J., Qiao, W., Hu, C., Ma, J., Dong, X., Dalangood, S., Li, H., Yuan, C., Lu, B., Gao, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2316727/v1
Dong, J., & Li, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2439125/v1
Kholod, O. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94231
Shaping of the Clinical Landscape of Immunotherapy by PD-L1 Expression in Breast Cancer
Terrero, D., Shanker, A., Tiwari, A. K., & Raman, D. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_176-1
Abate, M., Fei, T., Lin, Y. H., Shimada, S., Drebin, H. M., Chen, E., Tang, L. H., Strong, V. E. M., & Vardhana, S. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.29.534765
Meta-Narrative Review of PD-L1 by immunotherapy on Triple-Negative Breast Cancer
Lazo, H., Harris, T., Truong, H., & Masroor, A. (2023) · doi:10.52519/00112
You, H., Qian, H., Miao, S., Li, X., Liu, B., Zhang, D., Chen, Y., Ni, Q., & Sheng, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3176896/v1
Self-citationyuan, X., Wang, Y., Zhang, B., Dong, Z., Li, Q., Zhang, H., & Jiang, W. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4522410
Self-citationWu, S., Huang, H., Sun, R., Gao, D. S., Ye, F., Huang, J., Li, E., Ni, A., Lu, K. G., Chen, K., et al. (2023) · doi:10.1158/2767-9764.c.6740591.v2
Huang, Y., Yu, Y., Zhang, H., Zhang, Z., Zheng, Y., Wang, X., & Wang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3262118/v1
Self-citationFrozza, F. T. B., Pereira, G. F. P. D. M., & Bonorino, C. (2023) · Ageing and Cancer Research & Treatment · doi:10.37155/2972-4759-2023-01-01-3
The single-cell and spatial landscape of plasma cells in muscle-invasive bladder cancerPreprint
Zhou, L., Zhu, J., Yu, G., Li, M., & Xu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3331238/v1
Self-citationFattori, S., Roy, A. L., Houacine, J., Robert, L., Abès, R., Gorvel, L., Granjeaud, S., Rouviére, M.-S., Amara, A. B., Boucherit, N., et al. (2023) · doi:10.1158/0008-5472.24146019.v1
Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
Zhou, Q., Yuan, J., Wu, K., Yin, J., & Tan, L. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1426
Mietz, J., Kaulfuß, M., Egli, L., Opitz, L., Münz, C., & Chijioke, O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.11.561856
Li, Z., Xie, Q., Zhao, F., Ren, D., Liu, Z., Shen, G., & Zhao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3438252/v1
Self-citationLi, Z., Xie, Q., Zhao, F., Ren, D., Liu, Z., Shen, G., & Zhao, J. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4606850
Self-citationYan, H., Huang, J., Li, Y., & Zhao, B. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4608010
Schmid, P., Turner, N. C., Barrios, C. H., Isakoff, S. J., Kim, S., Sablin, M., Saji, S., Savas, P. S., Vidal, G. A., Oliveira, M., et al. (2024) · doi:10.1158/1078-0432.c.7077781.v1
Schmid, P., Turner, N. C., Barrios, C. H., Isakoff, S. J., Kim, S., Sablin, M., Saji, S., Savas, P. S., Vidal, G. A., Oliveira, M., et al. (2024) · doi:10.1158/1078-0432.c.7077781
Sathe, A., Ayala, C. I., Bai, X., Grimes, S. M., Lee, B., Kin, C., Shelton, A. A., Poultsides, G. A., & Ji, H. P. (2023) · Figshare · doi:10.6084/m9.figshare.24636475
Macrophage niches as conserved functional tissue building blocks
Matusiak, M., Trinh, A. T., & van de Rijn, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00003-5
Dendritic Cells in the Tumor Microenvironment
Shurin, M. R., & Umansky, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00009-0
An ALK1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastasesPreprint
Talkhoncheh, M. S., Sjölund, J., Bolívar, P., Kurzejamska, E., Cordero, E., Pagès, T. V., Larsson, S., Lehn, S., Frimannsson, G., Ingesson, V., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.15.599147
Chan, C. M. F., To, A., Zhang, S., Wong, J. W. H., Huang, Y., Chao, Y., & Sugimura, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.24.600550
Dynamic Tumor Immune Microenvironment Remodeling Predicts Response of Checkpoint Inhibitor TherapyPreprint
Lin, Z., Chandra, M., Srinivas, N., Ugurel, S., Becker, J. C., & Aran, D. (2025) · bioRxiv · doi:10.1101/2024.06.30.601413
Rationale for Immunotherapy for Breast Cancer
Karn, T. (2024) · Cancer immunotherapy · doi:10.1007/13905_2024_37
Systemic CD8+ T cell effector signature predicts prognosis of lung cancer immunotherapyPreprint
Sim, H., Park, G., Park, W., Lee, S., & Choi, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.16.613381
Reversing Immunosenescence with Senolytics to Enhance Tumor ImmunotherapyPreprint
Liu, N., Wu, J., Deng, E., Zhong, J., Wei, B. K., Cai, T., Duan, X., Fu, S., Osei-Hwedieh, D. O., Sha, O., et al. (2024) · medRxiv · doi:10.1101/2024.10.14.24315428
Yan, Q., Chang, W., Li, Z., Wong, W., Gong, L., Liang, D., Yang, J., Dai, S., & Wang, J. (2024) · Research Square · doi:10.21203/rs.3.rs-5264872/v1
Profiling Multiple CD8+ T-cell Functional Dimensions Enhances Breast Cancer Immune Assessment
Liang, Z., Li, S., Pan, Z., Duan, Y., Ouyang, Q., Zhu, L., Song, E., & Chen, K. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0235
Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer
Yi, X.-M., Cai, H.-Q., & Jiao, Y. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i2.100257
TNIP1 Impacts Prognosis by Modulating the Immune Microenvironment in BRCA
Liao, D.-J., Liu, W., Jiang, Y.-H., Zhao, P., & Yao, Y. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11034-1
HIDE: Hierarchical cell-type DeconvolutionPreprint
Voelkl, D., Mensching-Buhr, M., Sterr, T., Bolz, S., Schäfer, A., Seifert, N., Tauschke, J., Rayford, A. J., Straume, O., Zacharias, H. U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.31.634483
Emerging Biomarkers of Response to Immunotherapy: Host Characteristics in Breast Cancer
Mathesh, V., & Reddy, S. M. (2025) · Cancer immunotherapy · doi:10.1007/13905_2024_44
Xu, Y., Wang, S., Ding, L., Li, H., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.649953
Deciphering immune cell heterogeneity in vascular diseases: Insights from single-cell sequencing
Zeng, W., Zhang, Y., Zhong, W., Chen, L., Gao, Y., Li, C., Zhao, Y., Shen, C., Zhao, R., Shi, B., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114719
Self-citationPark, G., & Park, J. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag156
Zhao, R., Ding, D., Bao, M., Ding, Y., Ding, R., Liu, J., Yu, L., & Zhu, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-02649-2
CD4+ T cells in Antitumour Immunity
Bawden, E., & Gebhardt, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00187-3
Bottomly, D., ZHENG, C. L., Creason, A., Mitri, Z. I., Mills, G. B., & McWeeney, S. K. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00959-w · Cited by 1
Single cell analysis of pan-cancer tumor microenvironment in immunotherapy
Li, F., Xue, K., Pei, L., Sun, Y., Chen, Z., Zhang, Y., Song, K., Liu, W., Quan, Q., Gong, X., et al. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf101
Self-citationHIDE: hierarchical cell-type deconvolution
Voelkl, D., Mensching-Buhr, M., Sterr, T., Bolz, S., Schäfer, A., Seifert, N., Tauschke, J., Rayford, A. J., Straume, O., Zacharias, H. U., et al. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf179
MED8 is related to tumor immunity and has predictive value in the prognosis and treatment of glioma
Yang, J., Li, B., Zhang, X., Li, Y., & Yuan, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03259-8
Long, Y., Ling, J., Wei, W., Lv, Y., Guo, X., Sun, Y. Q., Jiao, J., Buerliesi, A., Li, L., Zhu, Y., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907875
Huang, X., Chen, W., Lin, Z., Zhang, H., Wang, R., & Lin, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-15157-8
Cell membrane-camouflaged nanoparticles boost combined chemo/immunotherapy for gastric cancer
Dong, X., Yu, M., Zhang, Y., Wang, L., Zhu, L., Wang, D., Yang, X., Zhang, M., Zheng, X., & Cai, H. (2025) · Nano Research · doi:10.26599/nr.2025.94907897
Self-citationSchachter, L. Z., Pinhasi, A., & Yizhak, K. (2025) · bioRxiv · doi:10.1101/2025.09.26.678647
Atlas of Breast Cancer in Chinese Young Women Revealed by Single-cell RNA and ATAC SequencingPreprint
Ruan, Z., Li, L., Xiang, W., Zhang, J., Liu, Y., Huang, Z., Wang, Y., Han, X. M., Yan, C., Ou, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.16.682857
Self-citationSystemic chemotherapy in metastatic TNBC polarizes effector T cell differentiation
Ju, H.-Y., Yoon, H., Jung, S. P., Park, S. I., Kim, T. K., & Han, M.-R. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04011-6
Ya, Z., Wu, H., Jia, W., Li, Y., Zhu, M., Zhang, L., Zong, Y., Guo, S., Bouakaz, A., & Wan, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7968444/v1
Current landscape of cross-line immune checkpoint blockade for cancer treatment
Fan, P., Wu, K., Zhu, C., & Guan, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218135
Self-citationThe impact of immune cells on the risk of breast cancer: a Mendelian randomization study
Zhang, N., Wang, H., Huang, Z., Shen, Z., Zhang, P., & Zhang, G. (2025) · Discover Oncology · doi:10.1007/s12672-025-04068-9
Novel approaches to immuno-oncology
Wu, Q. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00056-4
Cytometric assessment of antigen-specific T cell signaling
Walsh, Z. H., Shah, S., Melms, J. C., & Izar, B. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.11.003
Li, C., Zhang, L., Jin, Q., Jiang, H., Yue, N., & Wu, C. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.060
Wang, Y., Ji, H., Wang, H., & Song, Z. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106898
Self-citationMonoallelic expression characterizes a distinct molecular and clinical group of breast tumorsPreprint
Arabzadeh, M., Singh, A., Payne, K., Ganesan, S., & Khiabanian, H. (2025) · bioRxiv · doi:10.21203/rs.3.rs-8535132/v1
Yang, Q., Xu, L., Dong, W., Li, X., Wang, K., Dong, S., Luo, G., Zhang, X., Yang, T., Gao, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.09.693330
Ye, D., Desai, J., Shi, J., Liu, S.-Y. M., Shen, W., Liu, T., Shi, Y., Wang, D., Liang, L., Yang, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619075
Self-citationYan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693874
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693871
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693886
Hu, Y., Lou, X., Zhang, K., Pan, L., Bai, Y., Wang, L., Wang, M., Yan, Y., Wan, J., Yao, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26341981
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550820
Self-citationChen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550823
Self-citationYan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693844
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550808
Self-citationYan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693856
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693868
Ye, D., Desai, J., Shi, J., Liu, S.-Y. M., Shen, W., Liu, T., Shi, Y., Wang, D., Liang, L., Yang, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619072
Self-citationYan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693859
Fan, X., Qi, A., Zhang, M., Jia, Y., Li, S., Han, D., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26942529
Kong, L., Zheng, Q., He, Y., Zhong, J., An, T., Li, J., Chi, Y., Jia, B., Wang, J., Ji, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4173484/v1
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550811
Self-citationYang, C., Liu, J., Zhao, S., Shang, Q., Ren, F., Feng, K., Zhang, R., Kang, X., Wang, X., & Wang, X. (2023) · Figshare · doi:10.6084/m9.figshare.23354272
Metadata
- Authors
- Zhang, Y., Chen, H., Mo, H., Hu, X., Gao, R., Zhao, Y., Liu, B., Niu, L., Sun, X., Yu, X., Wang, Y., Chang, Q., Gong, T., Guan, X., Hu, T., Qian, T., Xu, B., Ma, F., Zhang, Z., & Liu, Z.
- Affiliations
- Peking University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
- Corresponding author
- Xu, Binghe
- Ma, Fei
- Zhang, Zemin
- Liu, Zhihua
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 39
- Issue
- 12
- Pages
- 1578-1593.e8
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3205385275
- Cited by
- 783
- References
- 77
- Citations by year
- 2026: 135 · 2025: 206 · 2024: 183 · 2023: 158 · 2022: 93 · 2021: 8
- FWCI
- 41.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31991171, 81988101, 82030089, 91942307)
- Chinese Academy of Meteorological Sciences (2016-I2M-1-001, 2017-I2M-3-004, 2019-I2M-1-003)
- Peking University
- Beijing Municipal Science and Technology Commission (Z201100005320014)
- National Key Research and Development Program of China (2018YFC1312101, 2020YFA0803300)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- triple-negative breast cancer, PD-L1 blockade, atezolizumab, paclitaxel, immune cell dynamics, lymphoid tissue inducer cells, follicular B cells, conventional type 1 dendritic cells, single-cell RNA sequencing, single-cell ATAC-seq
- MeSH terms
- Immune Checkpoint Inhibitors, Female, Humans, Single-Cell Analysis, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review